Last October, a 54-year-old attorney sat across from me in consultation and said something I hear at least twice a week: "I want stem cells. I read that they can reverse aging." She pointed to her midface, where volume loss had deepened her nasolabial folds and hollowed her temples. She was describing a real problem. But the solution she had in mind -- injectable "stem cell therapy" from a med spa -- would not fix it.
I spent the next twenty minutes explaining what was actually happening to her face -- and why a $12,000 "regenerative" treatment would likely disappoint her. That conversation is the one I want to have with you here.
The Anatomy Most Surgeons Gloss Over
When patients tell me their face is "falling," they are usually right, but not in the way they think. The malar fat pad -- that fullness over your cheekbone -- is not one structure. Rohrich and Pessa demonstrated in their 2007 Plastic and Reconstructive Surgery dissection study that what we call the "malar fat" is actually three distinct compartments: medial, middle, and lateral temporal-cheek, each separated by fibrous septae. These compartments do not age at the same rate. The medial compartment deflates first, which is why the nasolabial fold deepens before the lateral cheek flattens.
Go deeper, and the architecture gets more specific. Mendelson and Wong mapped five distinct soft tissue layers in their 2013 PRS cadaveric study, identifying a retaining ligament system that anchors the SMAS (the muscular layer beneath your skin) directly to bone. When these ligaments attenuate -- and they do, starting in your forties -- the entire soft tissue envelope shifts downward. This is not "sagging skin." It is structural failure at the ligament level.
I explain this to patients because it changes the treatment plan entirely. If you do not understand which compartment has lost volume, you cannot replace it accurately. And if you ignore the ligament system, you are putting filler into a face that is sliding off its scaffolding.
Fat Grafting: What the Data Actually Shows
I used to think fat grafting was straightforward -- harvest fat, inject it, and the body would incorporate it predictably. Then I watched my early cases at twelve months and realized that "predictable" was generous.
The technique that changed my approach was Coleman's structural fat grafting method, published in Clinics in Plastic Surgery in 1997. Low-pressure harvest to minimize adipocyte damage, centrifugation at 3000 rpm to separate viable fat from oil and blood, then micro-injection in multiple tissue planes using small aliquots. Each pass deposits roughly 0.1 cc. It is tedious. It takes me about forty minutes per side for a full midface case. But the survival rates justify the precision.
How much fat actually survives? The honest answer: 40-50% on average at three to twelve months, depending on the recipient site. Temple grafting is the most variable -- retention ranges from 32.6% to 65.7%, and the difference is almost entirely technique-dependent. I tell patients to expect about half of what I inject to remain at one year. Some colleagues promise more. I prefer to under-promise.
What I Would Not Do
"Can you just do a little fat transfer to my temples at the same time as my eyelids?" A patient asked me this in March. The answer was no. Temple grafting demands its own session, its own positioning, and meticulous layering against the deep temporal fascia. Combining it as an afterthought with another procedure is how you get contour irregularities that take months to resolve.
The Stem Cell Question -- Honestly
Here is where I will probably frustrate some colleagues who have built practices around "stem cell facelifts." The regenerative medicine hype in facial rejuvenation has outpaced the evidence by about a decade.
The best study we have is Verpaele and colleagues' multicenter randomized controlled trial, published in PRS in 2023. They compared SVF-enriched fat grafting (stromal vascular fraction, which contains adipose-derived stem cells) against standard fat grafting. The results: 74.5% graft survival in the SVF group versus 66.6% in controls at six weeks (p<0.025), and 71.3% versus 62.0% at twenty-four weeks (p<0.012).
That is a statistically significant difference. It is also, clinically, about 9 percentage points. In a case where I inject 20 cc of fat, that means roughly 1.8 cc more surviving tissue in the enriched group. Visible? Possibly. Worth the additional cost and processing time? That depends on what the patient is being charged and what they are being told.
What about PRP -- platelet-rich plasma -- as an adjunct? A split-face RCT of 18 patients found no significant difference in fat graft retention compared to saline. I stopped adding PRP to fat grafting cases two years ago. The evidence simply is not there.
The Five-Year Problem Nobody Talks About
Most fat grafting studies follow patients for six to twelve months. Buskens and colleagues published a five-year volumetric follow-up in the Journal of Plastic, Reconstructive & Aesthetic Surgery in 2025, and the findings should give every fat grafting surgeon pause.
At five years, graft retention correlated with patient weight change, not with the initial volume injected. Patients who gained weight saw their grafts expand. Patients who lost weight saw them shrink. The grafted fat behaved like native fat -- because it is native fat. This is not a flaw; it is biology. But it means the permanence that we advertise is conditional.
More sobering: FACE-Q patient satisfaction scores returned to baseline by five years. The median pre-operative score was 45.0. At five years, it was 39.0. Patients were, on average, no more satisfied with their appearance than before surgery. I share this data with every fat grafting consultation now. Not to discourage the procedure -- I still perform it regularly -- but because informed consent requires honest numbers, not marketing language.
What Regenerative Medicine Can Do -- the Nanofat Data
There is one regenerative application where I have seen genuinely compelling histology. Nanofat -- fat processed into an injectable emulsion containing almost no intact adipocytes but rich in stromal cells and growth factors -- has shown measurable tissue remodeling. Biopsy studies document elastic fiber density increasing from 171 plus or minus 9.5 to 266 plus or minus 17.3 (p<0.005). That is a 55% increase in elastic fiber content.
I use nanofat for skin quality improvement in areas where volume replacement is not the goal -- lower eyelid skin, perioral lines, dorsal hand skin. It is not a facelift. It does not replace structural fat grafting. But the histologic evidence for dermal remodeling is real, and I would rather offer patients something backed by tissue-level data than a branded "stem cell facial" backed by testimonials.
Back to My Patient
The attorney from October chose structural fat grafting to her midface and temples, without SVF enrichment. I harvested from her lateral thigh, centrifuged per Coleman's protocol, and placed 18 cc total across four compartments. At her six-month follow-up, she looked like herself -- but rested. Not frozen, not overfilled, not "done."
"I thought you were going to make me look younger," she said. "You made me look less tired. That's better."
That is what evidence-based facial rejuvenation actually delivers. Not reversal of aging. Not stem cell miracles. A face that looks like it belongs to someone who sleeps well and has good anatomy -- because we put the volume back where the anatomy lost it.
Dr. Sina Bari is a Stanford-trained plastic surgeon based in the San Francisco Bay Area. For more about his work and research interests, visit sinabarimd.com.
Frequently Asked Questions
How long does fat grafting to the face actually last?
Surviving fat cells are permanent in that they remain viable tissue, but five-year data from Buskens et al. (JPRAS 2025) shows that graft volume tracks with your body weight over time. If you gain weight, grafted areas may expand. If you lose weight, they shrink. Patient satisfaction scores tend to return to pre-operative baseline by five years, which is why I counsel patients that touch-up sessions may be needed.
Is stem cell fat grafting worth the extra cost?
SVF-enriched fat grafting showed about 9 percentage points better retention than standard grafting in the largest RCT to date (Verpaele et al., PRS 2023). On a typical 20 cc case, that translates to roughly 1.8 cc of additional surviving tissue. Whether that clinical difference justifies the added cost and processing time depends on individual goals and budget. I discuss the specific numbers with each patient rather than marketing it as a transformative upgrade.
Does PRP improve fat grafting results?
Based on the available split-face RCT data, PRP added to fat grafts did not produce a significant difference in retention compared to saline alone. I stopped using PRP as a fat grafting adjunct in my practice after reviewing this evidence. The theoretical rationale is sound, but the clinical data has not supported it.
What is the difference between structural fat grafting and nanofat?
Structural fat grafting transfers intact adipocytes (fat cells) to restore volume in areas like the cheeks, temples, and jawline. Nanofat is processed into an emulsion that contains almost no intact fat cells but is rich in stromal cells and growth factors. Nanofat does not add volume -- instead, biopsy data shows it increases elastic fiber density by about 55%, improving skin quality in areas like the lower eyelids and perioral region. I use them for different purposes: structural fat for volume, nanofat for skin texture.